Get the Stockscreener App
0.3979
0.28%
-0.0011
Aethlon Medical Inc stock is traded at $0.3979, with a volume of 159.67K.
It is down -0.28% in the last 24 hours and up +4.71% over the past month.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
See More
Previous Close:
$0.399
Open:
$0.389
24h Volume:
159.67K
Relative Volume:
1.07
Market Cap:
$6.40M
Revenue:
$294.20K
Net Income/Loss:
$-12.25M
P/E Ratio:
-0.0788
EPS:
-5.05
Net Cash Flow:
$-10.77M
1W Performance:
-1.19%
1M Performance:
+4.71%
6M Performance:
-1.58%
1Y Performance:
-2.95%
1-Day Range:
$0.38
$0.40
1-Week Range:
$0.38
$0.4256
52-Week Range:
$0.2375
$1.055
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.3979 | 6.48M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
131.30 | 234.53B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 156.88B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
376.62 | 150.65B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
80.68 | 110.81B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
74.99 | 45.75B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon Adds to Board - Medical Product Outsourcing
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtration System | AEMD Stock News - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma - Yahoo Finance
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
Aethlon Medical’s (AEMD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth - TipRanks
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Investorideas.com newswire
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Yahoo Finance
Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
HC Wainwright Boosts Earnings Estimates for Aethlon Medical - Defense World
Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World
Aethlon Medical strengthens oncology trial with protocol updates and cost reductions - MSN
Aethlon Medical IncThe company expects to conduct a capital raise that - Smartkarma
Aethlon’s Earnings Call: Trials and Cost Strategies - TipRanks
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Live Investor Update: Aethlon Medical Unveils Latest Cancer Treatment ProgressCEO Takes Questions - StockTitan
Aethlon Medical operating expenses drop 50% in Q3 2024 - Medical Buyer
Earnings call transcript: Aethlon Medical Q4 2024 sees cost cuts, stock rises - Investing.com Nigeria
Aethlon Medical Reports Q3 Results and Corporate Update - TipRanks
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):